Literature DB >> 7626134

Alteration of transcription factor binding activities in the ischemic rat brain.

A Salminen1, P K Liu, C Y Hsu.   

Abstract

Transient focal ischemia-reperfusion in the cerebral cortex caused regional alteration of DNA-binding activities of transcription factors AP-1, CREB, Sp-1, and NF-kB. The changes were time-dependent. During the first 24 hr of reperfusion after 90 min ischemia, there was an increase in the binding activity of AP-1 only in the region surrounding the ischemic cortex. Five days after ischemia, an increase in the binding activities of CREB, Sp-1, and NF-kB, but not AP-1, was noted in the ischemic cortex, and to a lesser extent, Sp-1 and NF-kB, in the surrounding region. The binding activities of these transcription factors were reduced by hydrogen peroxide but could be restored by dithiothreitol and 2-mercaptoethanol. These results are the first demonstration of ischemia-induced differential regulation of transcription factor binding activities which are time-, region-, and redox state dependent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626134     DOI: 10.1006/bbrc.1995.2060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  Transcripts of damaged genes in the brain during cerebral oxidative stress.

Authors:  Philip K Liu; Tarun Arora
Journal:  J Neurosci Res       Date:  2002-12-15       Impact factor: 4.164

3.  Differential expression of genes at stages when regeneration can and cannot occur after injury to immature mammalian spinal cord.

Authors:  Miranda Mladinic; Marie Wintzer; Elaine Del Bel; Cristina Casseler; Dejan Lazarevic; Sergio Crovella; Stefano Gustincich; Antonino Cattaneo; John Nicholls
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

Review 4.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

5.  Neuronal NOS inhibitor that reduces oxidative DNA lesions and neuronal sensitivity increases the expression of intact c-fos transcripts after brain injury.

Authors:  J Cui; P K Liu
Journal:  J Biomed Sci       Date:  2001 Jul-Aug       Impact factor: 8.410

6.  Computational identification of conserved transcription factor binding sites upstream of genes induced in rat brain by transient focal ischemic stroke.

Authors:  John V K Pulliam; Zhenfeng Xu; Gregory D Ford; Cuimei Liu; Yonggang Li; Kyndra C Stovall; Virginetta S Cannon; Teclemichael Tewolde; Carlos S Moreno; Byron D Ford
Journal:  Brain Res       Date:  2012-12-11       Impact factor: 3.252

7.  Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion.

Authors:  P K Liu; C Y Hsu; M Dizdaroglu; R A Floyd; Y W Kow; A Karakaya; L E Rabow; J K Cui
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

8.  Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses.

Authors:  Wataru Komaki; Tsuyoshi Fukushima; Hiroyuki Tanaka; Hiroshi Itoh; Etsuo Chosa; Hiroaki Kataoka
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

Review 9.  The association between neuronal nitric oxide synthase and neuronal sensitivity in the brain after brain injury.

Authors:  Philip K Liu; Claudia S Robertson; Alex Valadka
Journal:  Ann N Y Acad Sci       Date:  2002-05       Impact factor: 5.691

10.  Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide.

Authors:  J K Cui; C Y Hsu; P K Liu
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.